229 related articles for article (PubMed ID: 15161669)
41. Perspectives on familial chronic lymphocytic leukemia: genes and the environment.
Caporaso N; Marti GE; Goldin L
Semin Hematol; 2004 Jul; 41(3):201-6. PubMed ID: 15269880
[TBL] [Abstract][Full Text] [Related]
42. Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia.
Baecklund F; Ekberg S; Rosenquist R; Askling J; Eloranta S; Smedby KE
Eur J Haematol; 2020 Dec; 105(6):779-785. PubMed ID: 32871627
[TBL] [Abstract][Full Text] [Related]
43. Familial Risks of Tourette Syndrome and Chronic Tic Disorders. A Population-Based Cohort Study.
Mataix-Cols D; Isomura K; Pérez-Vigil A; Chang Z; Rück C; Larsson KJ; Leckman JF; Serlachius E; Larsson H; Lichtenstein P
JAMA Psychiatry; 2015 Aug; 72(8):787-93. PubMed ID: 26083307
[TBL] [Abstract][Full Text] [Related]
44. Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia.
Auer RL; Dighiero G; Goldin LR; Syndercombe-Court D; Jones C; McElwaine S; Newland AC; Fegan CD; Caporaso N; Cotter FE
Br J Haematol; 2007 Jan; 136(1):73-9. PubMed ID: 17116127
[TBL] [Abstract][Full Text] [Related]
45. Sex- and kindred-specific familial risk of non-Hodgkin's lymphoma.
Czene K; Adami HO; Chang ET
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2496-9. PubMed ID: 18006943
[TBL] [Abstract][Full Text] [Related]
46. Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).
Meacham PJ; Williams AM; Strawderman M; Baran AM; Archibald WJ; Wallace DS; Tschernia NP; Burack WR; Barr PM; Zent CS
Leuk Lymphoma; 2020 Jul; 61(7):1636-1644. PubMed ID: 32175786
[TBL] [Abstract][Full Text] [Related]
47. Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
Ahmad E; Steinberg SM; Goldin L; Hess CJ; Caporaso N; Kreitman RJ; Wiestner A; Wilson W; White T; Marti G; Stetler-Stevenson M
Cytometry B Clin Cytom; 2008 Jul; 74(4):221-6. PubMed ID: 18431797
[TBL] [Abstract][Full Text] [Related]
48. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
[TBL] [Abstract][Full Text] [Related]
49. The influence of MTHFR C677T polymorphism in chronic lymphocytic leukemia.
Reis AADS; de Alcântara KC; de Farias DLC; Dos Anjos LRB; Rodrigues DA; Pedrino GR; Santos RDS
Electrophoresis; 2019 Jul; 40(12-13):1715-1718. PubMed ID: 31020666
[TBL] [Abstract][Full Text] [Related]
50. The influence of parental age and gender on anticipation in familial B-cell malignancies.
Alexandrescu DT; Wiernik PH
Med Oncol; 2007; 24(1):55-62. PubMed ID: 17673812
[TBL] [Abstract][Full Text] [Related]
51. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion.
Rawstron AC; Yuille MR; Fuller J; Cullen M; Kennedy B; Richards SJ; Jack AS; Matutes E; Catovsky D; Hillmen P; Houlston RS
Blood; 2002 Oct; 100(7):2289-90. PubMed ID: 12239136
[TBL] [Abstract][Full Text] [Related]
52. Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases.
Adank MA; Verhoef S; Oldenburg RA; Schmidt MK; Hooning MJ; Martens JW; Broeks A; Rookus M; Waisfisz Q; Witte BI; Jonker MA; Meijers-Heijboer H
Eur J Cancer; 2013 May; 49(8):1993-9. PubMed ID: 23415889
[TBL] [Abstract][Full Text] [Related]
53. Familial chronic lymphocytic leukemia.
Cerny J; Slavickova A; Krepelova A; Trneny M; Karban J; Klener P
Haematologica; 2003 Oct; 88(10):1190-1. PubMed ID: 14555317
[TBL] [Abstract][Full Text] [Related]
54. Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?
van den Broek EC; Liu L; Posthuma EF; Janssen-Heijnen ML; Coebergh JW; Soerjomataram I
Ann Hematol; 2014 Jan; 93(1):157-62. PubMed ID: 24381068
[TBL] [Abstract][Full Text] [Related]
55. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
56. Familial CLL: genes and environment.
Goldin LR; Slager SL
Hematology Am Soc Hematol Educ Program; 2007; ():339-45. PubMed ID: 18024649
[TBL] [Abstract][Full Text] [Related]
57. Genetic variation and risk of chronic lymphocytic leukaemia.
Crowther-Swanepoel D; Houlston RS
Semin Cancer Biol; 2010 Dec; 20(6):363-9. PubMed ID: 20833250
[TBL] [Abstract][Full Text] [Related]
58. Instability of CAG-trinucleotide repeats in chronic lymphocytic leukemia.
Benzow KA; Koob MD; Condie A; Catovsky D; Matutes E; Yuille MR; Houlston RS
Leuk Lymphoma; 2002 Oct; 43(10):1987-90. PubMed ID: 12481897
[TBL] [Abstract][Full Text] [Related]
59. Nonrandom occurrence of lymphoid cancer types in 140 families.
Jones SJ; Voong J; Thomas R; English A; Schuetz J; Slack GW; Graham J; Connors JM; Brooks-Wilson A
Leuk Lymphoma; 2017 Sep; 58(9):1-10. PubMed ID: 28278712
[TBL] [Abstract][Full Text] [Related]
60. Familial chronic lymphocytic leukemia.
Houlston RS; Catovsky D
Curr Hematol Malig Rep; 2008 Oct; 3(4):221-5. PubMed ID: 20425469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
